LPL Financial’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$304K Buy
28,375
+585
+2% +$6.54K ﹤0.01% 5516
2026
Q2
$305K Buy
27,790
+12,994
+88% +$123K ﹤0.01% 5438
2026
Q1
$120K Buy
14,796
+4,691
+46% +$40.3K ﹤0.01% 5636
2025
Q4
$105K Buy
+10,105
New +$106K ﹤0.01% 5584

Other funds holding KURA

LPL Financial's KURA Position: Q3 2026 in Review

LPL Financial increased its Kura Oncology (KURA) stake by 2.1% in Q3 2026, buying an estimated $6.54K and bringing the position to 28,375 shares worth $304K. The position accounts for ﹤0.01% of the portfolio, ranked #5516.

LPL Financial first reported a position in KURA in Q4 2025 and has held it in 4 quarters since. The position peaked at $305K in Q2 2026. 84 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

  • LPL Financial held 28,375 shares of Kura Oncology worth $304K as of Q3 2026.
  • LPL Financial bought 585 Kura Oncology shares in Q3 2026, an estimated $6.54K.
  • Kura Oncology made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #5516 holding.
  • LPL Financial first reported a position in Kura Oncology in Q4 2025 and has held it in 4 quarters since.
  • LPL Financial's Kura Oncology position peaked at $305K in Q2 2026.
  • 84 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.